The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (2 analysts) rates it none, with a mean price target of $42.
Old Republic International Corporation
ORI · the NYSE · USD · Market cap $9.9B · 9,500 employees
Old Republic International Corporation, through its subsidiaries, provides insurance underwriting and related services in the United States and Canada.
FAIL · Does not pass the screenAt the last full screen
2026-09-10
Screened 2026-09-10 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Old Republic International Corporation holds its Markdown at $40.84. The statistical read favours the sellers, held for 3 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 3 days |
| Price at the screen | $40.84 |
| Valuation | 8.96 trailing · 12.38 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.62 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: insurance
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: insurance | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. A 13.9% margin of safety to the base estimate.
Third-party analyst targets: 2 covering, consensus None. The average target sits +7% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsEthical screen rules out this insurer outright
Think of an adjuster driving out after a Midwest storm to settle claims on homes and businesses. That is the core work at Old Republic in its specialty and title books. Our screen still blocks the name because the entire insurance sector sits on the prohibited list.
Revenue is growing 14 percent and return on equity reaches 17 percent, yet the forward multiple sits at just 12.7 times with almost no margin of safety above the current price. Analyst targets cluster around the same level, so the numbers offer little extra pull once ethics close the door.
Property and casualty books swing with claim volumes and pricing cycles that can turn quickly. The screen keeps us out of the sector for that reason as well. Analysis, not advice.
| Forward P/E | 12.4xfairly priced for its growth rate |
| Trailing P/E | 9.0xvery cheap relative to earnings |
| EPS, trailing | 4.56 |
| EPS, forward | 3.30 |
| Revenue growth | +13.4%steady growth |
| Profit margin | 11.7%thin but positive margins |
| Return on equity | 18.6%a solid return on shareholder capital |
| FCF yield | 14.39% |
| Dividend yield | 327.00% |
| Debt to equity | 0.38minimal debt: a conservative balance sheet |
| Current ratio | 0.29below 1: short-term bills exceed liquid assets |
| Beta | 0.62steadier than the market |
| Short interest, float | 0.05% |
| 52-week range | 36.65 - 46.76 |
| Market cap | $9.9B |
| Employees | 9,500 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeORI trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (2 analysts) rates it none, with a mean price target of $42.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (2 analysts) rates it none, with a mean price target of $42.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 9 Apr2026 | Scott Peters | Democrat | buy | 50K–100K |
| 8 Apr2026 | Mike Kelly | Republican | buy | 50K–100K |
| 7 Feb2025 | Rick Scott | Republican | sell | 500K–1M |
| 7 Feb2025 | Rick Scott | Republican | sell | 500K–1M |
| 7 Feb2025 | Rick Scott | Republican | sell | 500K–1M |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $38.89 | -1.2% | $0.32 | $996 | -0.4% |
| 2 months | $40.51 | -5.2% | $0.32 | $956 | -4.4% |
| 3 months | $39.66 | -3.2% | $0.32 | $976 | -2.4% |
| 6 months | $41.36 | -7.1% | $3.13 | $1,004 | +0.4% |
| 1 year | $33.43 | +14.9% | $3.71 | $1,260 | +26.0% |
| 2 years | $25.68 | +49.6% | $6.82 | $1,761 | +76.1% |
| 3 years | $20.56 | +86.8% | $7.84 | $2,250 | +125.0% |
| 5 years | $17.88 | +114.8% | $12.19 | $2,830 | +183.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ORI does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.